Nature of Disclosure: Regulatory intimation of upcoming board meeting and trading window closure period.

Board Meeting Details:

  • A meeting of the Board of Directors is scheduled for Monday, July 27, 2026
  • Primary agenda: To consider and approve the Unaudited (Standalone and Consolidated) financial results for the quarter ended June 30, 2026 (Q1 FY27)
  • The meeting is being convened pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Trading Window Closure:

  • The Trading Window for dealing in securities of the Company has been closed effective Wednesday, July 01, 2026
  • The closure will remain in effect until 48 hours after the declaration of the unaudited financial results
  • The window will reopen after Wednesday, July 29, 2026 (both start and end dates inclusive)
  • This closure is in compliance with the company's Code of Conduct for Prevention and Prohibition of Insider Trading and SEBI (Prohibition of Insider Trading) Regulations, 2015

Additional Information:

  • The disclosure was signed by Shailesha Barve, Company Secretary & Compliance Officer (Membership No. A50601)

Financial Impact: Not quantified in this disclosure. The meeting is for consideration and approval of quarterly results.